FDA drafts guidance on using ‘generally accepted’ knowledge to support drug approvals
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesComplianceNorth AmericaPharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesComplianceNorth AmericaPharmaceuticalsPreclinical studyRegulatory Intelligence/Policy